© The Authors (2008). Published by Oxford University Press. All rights reserved
Plasma Levels of Prothrombin Fragment F1+2, D-dimer and Prothrombin Time Correlate with Clinical Stage and Lymph Node Metastasis in Operable Gastric Cancer Patients
1 Departments of Internal Medicine, Surgery, Dong-A University College of Medicine, Busan, South Korea
2 Departments of Internal Medicine, Laboratory Medicine, Surgery, Dong-A University College of Medicine, Busan, South Korea
3 Departments of Internal Medicine, Surgery, Dong-A University College of Medicine, Busan, South Korea
For reprints and all correspondence: Hyo-Jin Kim, Department of Internal Medicine, Dong-A University College of Medicine, 3-1 Dongdaeshin-dong, Seo-gu, Busan 602-715, South Korea. E-mail: kimhj{at}dau.ac.kr
Received July 4, 2007; accepted October 23, 2007
Objective: The principal objective of this study was to determine the relationship between preoperative coagulation tests and the extent of tumor involvement in gastric cancer patients.
Method: A total of 110 patients with adenocarcinoma of the stomach were studied in order to evaluate this relationship. Platelet count (P), prothrombin time (PT), activated partial thromboplastin time, D-dimer, fibrinogen degradation product, thrombin–antithrombin complex and prothrombin fragment F1+2 (F1+2) were evaluated.
Results: The D-dimer levels were positively correlated with the depth of invasion (P =0.007). Plasma D-dimer and PT were highly correlated with degree of lymph node involvement (P = 0.006, 0.004, respectively). D-dimer level, PT and plasma F1+2 level were correlated with clinical stage (P = 0.001, 0.017, 0.031, respectively). PT and F1+2 levels were significant in the prediction of the presence of lymph node involvement on the multivariate logistic regression models (odds ratio 2502.081 (5.977–1047425.4); P = 0.010 and odds ratio 19.487 (1.495–253.936); P = 0.023, respectively).
Conclusion: PT and plasma levels of F1+2 and D-dimer could be markers of degree or presence of lymph node involvement and clinical stage in patients with operable gastric cancer.
Key Words: coagulation test gastric cancer